← Evidence map

ArticlePharmaceutics2024

Commercialization of the Xalkori Pediatric Multiparticulate Product Using Quality-by-Design Principles.

Jeremy Bartlett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39204372